Cargando…

Physician-Modified TEVAR versus Hybrid Repair of the Proximal Descending Thoracic Aorta

There are different surgical options for the treatment of proximal lesions of the descending thoracic aorta. The aim of this study was to compare the outcome of physician-modified TEVAR (pmTEVAR) vs. hybrid repair of the thoracic aorta in terms of TEVAR with carotid-subclavian bypass (hdTEVAR). This...

Descripción completa

Detalles Bibliográficos
Autores principales: Yordanov, Miroslav Dimitrov, Oberhuber, Alexander, Ibrahim, Abdulhakim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225072/
https://www.ncbi.nlm.nih.gov/pubmed/35743525
http://dx.doi.org/10.3390/jcm11123455
_version_ 1784733529359253504
author Yordanov, Miroslav Dimitrov
Oberhuber, Alexander
Ibrahim, Abdulhakim
author_facet Yordanov, Miroslav Dimitrov
Oberhuber, Alexander
Ibrahim, Abdulhakim
author_sort Yordanov, Miroslav Dimitrov
collection PubMed
description There are different surgical options for the treatment of proximal lesions of the descending thoracic aorta. The aim of this study was to compare the outcome of physician-modified TEVAR (pmTEVAR) vs. hybrid repair of the thoracic aorta in terms of TEVAR with carotid-subclavian bypass (hdTEVAR). This was a single-centre, retrospective comparative study of all patients who underwent pmTEVAR and hybrid repair of the proximal descending aorta from January 2018 to June 2021. Primary outcomes were technical success, 30-day mortality, perioperative stroke, 30-day reinterventions and supraaortic access related complications. Secondary outcomes were patient survival, late complications, late reinterventions, and bypass/bridging stent patency. A total of 181 patients underwent TEVAR within the period of 42 months. In our study, only patients with proximal landing in zone 2 (n = 39) were included. A total of 5 of 15 pmTEVAR and 8 of 24 hybrid repair operations (33% vs. 33%, respectively) were performed due to aneurysms. Among the rest of the patients, 10 of 15 pmTEVAR and 16 of 24 hybrid operations (67% vs. 67%) were performed due to aortic dissection. Technical success was achieved in 100% of the patients. No significant difference in terms of postoperative complications could be detected in the early and midterm follow up period. The 30-day mortality was 12.5% in the hybrid repair group (n = 3) vs. 6.66% (n = 1) in the pmTEVAR group (p = 0.498). These patients underwent the operation in an emergency setting. No patient died after an elective operation. The causes of early mortality were major stroke (n = 2), haemorrhagic shock (n = 1) in the hybrid group and progredient spinal cord ischemia with tetraplegia and acute respiratory insufficiency (n = 1) in the pmTEVAR group. In conclusion, both therapies are robust techniques, with comparable patency rate and perioperative complications. pmTEVAR appears to be advantageous in terms of operation time and tendency to lower mortality rates.
format Online
Article
Text
id pubmed-9225072
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92250722022-06-24 Physician-Modified TEVAR versus Hybrid Repair of the Proximal Descending Thoracic Aorta Yordanov, Miroslav Dimitrov Oberhuber, Alexander Ibrahim, Abdulhakim J Clin Med Article There are different surgical options for the treatment of proximal lesions of the descending thoracic aorta. The aim of this study was to compare the outcome of physician-modified TEVAR (pmTEVAR) vs. hybrid repair of the thoracic aorta in terms of TEVAR with carotid-subclavian bypass (hdTEVAR). This was a single-centre, retrospective comparative study of all patients who underwent pmTEVAR and hybrid repair of the proximal descending aorta from January 2018 to June 2021. Primary outcomes were technical success, 30-day mortality, perioperative stroke, 30-day reinterventions and supraaortic access related complications. Secondary outcomes were patient survival, late complications, late reinterventions, and bypass/bridging stent patency. A total of 181 patients underwent TEVAR within the period of 42 months. In our study, only patients with proximal landing in zone 2 (n = 39) were included. A total of 5 of 15 pmTEVAR and 8 of 24 hybrid repair operations (33% vs. 33%, respectively) were performed due to aneurysms. Among the rest of the patients, 10 of 15 pmTEVAR and 16 of 24 hybrid operations (67% vs. 67%) were performed due to aortic dissection. Technical success was achieved in 100% of the patients. No significant difference in terms of postoperative complications could be detected in the early and midterm follow up period. The 30-day mortality was 12.5% in the hybrid repair group (n = 3) vs. 6.66% (n = 1) in the pmTEVAR group (p = 0.498). These patients underwent the operation in an emergency setting. No patient died after an elective operation. The causes of early mortality were major stroke (n = 2), haemorrhagic shock (n = 1) in the hybrid group and progredient spinal cord ischemia with tetraplegia and acute respiratory insufficiency (n = 1) in the pmTEVAR group. In conclusion, both therapies are robust techniques, with comparable patency rate and perioperative complications. pmTEVAR appears to be advantageous in terms of operation time and tendency to lower mortality rates. MDPI 2022-06-16 /pmc/articles/PMC9225072/ /pubmed/35743525 http://dx.doi.org/10.3390/jcm11123455 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yordanov, Miroslav Dimitrov
Oberhuber, Alexander
Ibrahim, Abdulhakim
Physician-Modified TEVAR versus Hybrid Repair of the Proximal Descending Thoracic Aorta
title Physician-Modified TEVAR versus Hybrid Repair of the Proximal Descending Thoracic Aorta
title_full Physician-Modified TEVAR versus Hybrid Repair of the Proximal Descending Thoracic Aorta
title_fullStr Physician-Modified TEVAR versus Hybrid Repair of the Proximal Descending Thoracic Aorta
title_full_unstemmed Physician-Modified TEVAR versus Hybrid Repair of the Proximal Descending Thoracic Aorta
title_short Physician-Modified TEVAR versus Hybrid Repair of the Proximal Descending Thoracic Aorta
title_sort physician-modified tevar versus hybrid repair of the proximal descending thoracic aorta
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225072/
https://www.ncbi.nlm.nih.gov/pubmed/35743525
http://dx.doi.org/10.3390/jcm11123455
work_keys_str_mv AT yordanovmiroslavdimitrov physicianmodifiedtevarversushybridrepairoftheproximaldescendingthoracicaorta
AT oberhuberalexander physicianmodifiedtevarversushybridrepairoftheproximaldescendingthoracicaorta
AT ibrahimabdulhakim physicianmodifiedtevarversushybridrepairoftheproximaldescendingthoracicaorta